Author： Ballanger B. Gil R. Audiffren M. Desmurget M.
Publisher： Springer Publishing Company
ISSN： 0014-4819
Source： Experimental Brain Research, Vol.179, Iss.2, 2007-05, pp. : 245-253
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Melatonin in Parkinson's disease
By Medeiros C.
Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. :
Access to resources
Recommend
A vaccine for Parkinson’s disease?
Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. :
Pathophysiology of Parkinson’s disease
By Mandir Allen S. Vaughan Christina
International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. :
Risk factors and prodromal markers and the development of Parkinson’s disease
By Lerche Stefanie Seppi Klaus Behnke Stefanie Liepelt-Scarfone Inga Godau Jana Mahlknecht Philipp Gaenslen Alexandra Brockmann Kathrin Srulijes Karin Huber Heiko Wurster Isabel Stockner Heike Kiechl Stefan Willeit Johann Gasperi Arno Fassbender Klaus Poewe Werner Berg Daniela
Journal of Neurology, Vol. 261, Iss. 1, 2014-01 ,pp. :
Clinical predictive factors of subthalamic stimulation in Parkinson’s disease
By Cornu P.
Brain, Vol. 125, Iss. 3, 2002-03 ,pp. :